deltatrials
Recruiting PHASE4 INTERVENTIONAL 2-arm NCT02342444

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

A Prospective Randomized Trial Comparing Two Standard Doses of Enoxaparin for the Prevention of Thromboembolism in Surgical Patients

Sponsor: Oregon Health and Science University

Conditions Deep Vein Thrombosis (DVT) Surgery Thromboembolic Events Trauma
Interventions Enoxaparin Sodium Injection 30 mg BID Enoxaparin Sodium Injection 40 mg QD
Updated 11 times since 2017 Last updated: Apr 1, 2024 Started: Feb 28, 2014 Primary completion: Dec 31, 2024 Completion: Mar 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02342444, this PHASE4 trial focuses on Deep Vein Thrombosis (DVT) and Surgery and remains actively recruiting participants. Sponsored by Oregon Health and Science University, it has been updated 11 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotUnknown Status~Feb 2019 – ~Feb 2020 · 12 months · monthly snapshotRecruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotRecruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotRecruiting~Apr 2021 – ~May 2022 · 13 months · monthly snapshotRecruiting~May 2022 – ~Dec 2023 · 19 months · monthly snapshotRecruiting~Dec 2023 – ~May 2024 · 5 months · monthly snapshotRecruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – present · 24 months · monthly snapshotRecruiting

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE4

  3. May 2024 — Jul 2024 [monthly]

    Recruiting PHASE4

  4. Dec 2023 — May 2024 [monthly]

    Recruiting PHASE4

  5. May 2022 — Dec 2023 [monthly]

    Recruiting PHASE4

▶ Show 6 earlier versions

  1. Apr 2021 — May 2022 [monthly]

    Recruiting PHASE4

  2. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE4

  3. Feb 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  4. Feb 2019 — Feb 2020 [monthly]

    Recruiting PHASE4

    Status: Unknown Status → Recruiting · Phase: NA → PHASE4

  5. Jun 2018 — Feb 2019 [monthly]

    Unknown Status NA

  6. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oregon Health and Science University
Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations